Literature DB >> 23671930

E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V.

Salomé S Pinho1, Joana Figueiredo, Joana Cabral, Sandra Carvalho, Joana Dourado, Ana Magalhães, Fátima Gärtner, Ana Maria Mendonfa, Tomoya Isaji, Jianguo Gu, Fátima Carneiro, Raquel Seruca, Naoyuki Taniguchi, Celso A Reis.   

Abstract

BACKGROUND: E-cadherin is a cell-cell adhesion molecule and the dysfunction of which is a common feature of more than 70% of all invasive carcinomas, including gastric cancer. Mechanisms behind the loss of E-cadherin function in gastric carcinomas include mutations and silencing at either the DNA or RNA level. Nevertheless, in a high percentage of gastric carcinoma cases displaying E-cadherin dysfunction, the mechanism responsible for E-cadherin dysregulation is unknown. We have previously demonstrated the existence of a bi-directional cross-talk between E-cadherin and two major N-glycan processing enzymes, N-acetylglucosaminyltransferase-III or -V (GnT-III or GnT-V).
METHODS: In the present study, we have characterized the functional implications of the N-glycans catalyzed by GnT-III and GnT-V on the regulation of E-cadherin biological functions and in the molecular assembly and stability of adherens-junctions in a gastric cancer model. The results were validated in human gastric carcinoma samples.
RESULTS: We demonstrated that GnT-III induced a stabilizing effect on E-cadherin at the cell membrane by inducing a delay in the turnover rate of the protein, contributing for the formation of stable and functional adherens-junctions, and further preventing clathrin-dependent E-cadherin endocytosis. Conversely, GnT-V promotes the destabilization of E-cadherin, leading to its mislocalization and unstable adherens-junctions with impairment of cell-cell adhesion.
CONCLUSIONS: This supports the role of GnT-III on E-cadherin-mediated tumor suppression, and GnT-V on E-cadherin-mediated tumor invasion. GENERAL SIGNIFICANCE: These results contribute to fill the gap of knowledge of those human carcinoma cases harboring E-cadherin dysfunction, opening new insights into the molecular mechanisms underlying E-cadherin regulation in gastric cancer with potential translational clinical applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23671930     DOI: 10.1016/j.bbagen.2012.10.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  44 in total

1.  Deregulation of the cell polarity protein Lethal giant larvae 2 (Lgl2) correlates with gastric cancer progression.

Authors:  Kyung Han Nam; Min A Kim; Gheeyoung Choe; Woo Ho Kim; Hye Seung Lee
Journal:  Gastric Cancer       Date:  2013-12-13       Impact factor: 7.370

2.  The absence of core fucose up-regulates GnT-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan function.

Authors:  Ayako Kurimoto; Shinobu Kitazume; Yasuhiko Kizuka; Kazuki Nakajima; Ritsuko Oka; Reiko Fujinawa; Hiroaki Korekane; Yoshiki Yamaguchi; Yoshinao Wada; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

3.  Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer.

Authors:  S Carvalho; T A Catarino; A M Dias; M Kato; A Almeida; B Hessling; J Figueiredo; F Gärtner; J M Sanches; T Ruppert; E Miyoshi; M Pierce; F Carneiro; D Kolarich; R Seruca; Y Yamaguchi; N Taniguchi; C A Reis; S S Pinho
Journal:  Oncogene       Date:  2015-07-20       Impact factor: 9.867

4.  Specific N-glycan alterations are coupled in EMT induced by different density cultivation of MCF 10A epithelial cells.

Authors:  Qingsong Xu; Xueming Niu; Wenjing Wang; Wen Yang; Yuguang Du; Jianguo Gu; Linsheng Song
Journal:  Glycoconj J       Date:  2016-12-29       Impact factor: 2.916

5.  N-Glycosylation regulates ligand-dependent activation and signaling of vascular endothelial growth factor receptor 2 (VEGFR2).

Authors:  Kevin Brown Chandler; Deborah R Leon; Jenevieve Kuang; Rosana D Meyer; Nader Rahimi; Catherine E Costello
Journal:  J Biol Chem       Date:  2019-07-15       Impact factor: 5.157

6.  I-branched carbohydrates as emerging effectors of malignant progression.

Authors:  Charles J Dimitroff
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

7.  Metabolic control of T cell immune response through glycans in inflammatory bowel disease.

Authors:  Ana M Dias; Alexandra Correia; Márcia S Pereira; Catarina R Almeida; Inês Alves; Vanda Pinto; Telmo A Catarino; Nuno Mendes; Magdalena Leander; M Teresa Oliva-Teles; Luís Maia; Cristina Delerue-Matos; Naoyuki Taniguchi; Margarida Lima; Isabel Pedroto; Ricardo Marcos-Pinto; Paula Lago; Celso A Reis; Manuel Vilanova; Salomé S Pinho
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-02       Impact factor: 11.205

Review 8.  Glycosylation in cancer: mechanisms and clinical implications.

Authors:  Salomé S Pinho; Celso A Reis
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

Review 9.  Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.

Authors:  Gordon Greville; Amanda McCann; Pauline M Rudd; Radka Saldova
Journal:  Epigenetics       Date:  2016-09-30       Impact factor: 4.528

10.  N-Acetylglucosaminyltransferase III (GnT-III) but not N-Acetylgalactosaminyltransferase-6 and 8 are Differentially Expressed in Invasive and In Situ Ductal Carcinoma of the Breast.

Authors:  Antônio Felix da Silva Filho; Gabriela Souto Vieira-de-Mello; Petra Barros Dos Santos; Moacyr Jesus Barreto de Melo Rêgo; Alfredo Ribeiro-Silva; Eduardo Isidoro Carneiro Beltrão
Journal:  Pathol Oncol Res       Date:  2019-01-28       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.